These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6133305)

  • 1. Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats.
    Rupniak NM; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1983; 79(2-3):226-30. PubMed ID: 6133305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.
    Gunne LM; Growdon J; Glaeser B
    Psychopharmacology (Berl); 1982; 77(2):134-9. PubMed ID: 6126902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats.
    Rupniak NM; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1985; 85(1):71-9. PubMed ID: 2858901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements.
    Chesler EJ; Salamone JD
    Pharmacol Biochem Behav; 1996 Jul; 54(3):619-24. PubMed ID: 8743638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacology (Berl); 1976 Dec; 51(1):15-22. PubMed ID: 13446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.
    Stewart BR; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1988; 96(1):55-62. PubMed ID: 2906443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1989; 98(3):372-9. PubMed ID: 2568657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1993; 112(4):428-36. PubMed ID: 7871053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity.
    Kelley AE; Bakshi VP; Delfs JM; Lang CG
    Psychopharmacology (Berl); 1989; 99(4):542-9. PubMed ID: 2594921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.
    Murugaiah KD; Ukponmwan OE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):294-300. PubMed ID: 13680087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration.
    Gunne LM; Andersson U; Bondesson U; Johansson P
    Pharmacol Biochem Behav; 1986 Oct; 25(4):897-901. PubMed ID: 2878445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias.
    Kelley JJ; Roberts RC
    J Neural Transm (Vienna); 2004 Aug; 111(8):1075-91. PubMed ID: 15254795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
    Tamminga CA; Dale JM; Goodman L; Kaneda H; Kaneda N
    Psychopharmacology (Berl); 1990; 102(4):474-8. PubMed ID: 1982902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ; McGonigle P; Luthin GR; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1988 Mar; 244(3):987-93. PubMed ID: 2908050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.